The research team, led by Sukalyan Kundu of Jahangirnagar University and including scientists from several other institutions, first established the safety profile of the extract through a series of laboratory tests. They found that the methanol extract, known in the study as MEHFL, was non-toxic in cell culture and showed no signs of acute toxicity in animal models at the doses used in the study. This safety profile was crucial for the subsequent antidiabetic testing, as it allowed the researchers to use higher doses of the extract in their animal models without risking harm to the animals.

With safety established, the researchers turned to the antidiabetic activity of the extract. They found that MEHFL significantly inhibited two key digestive enzymes, alpha-amylase and alpha-glucosidase, which are involved in the breakdown of starch and glucose metabolism. Inhibition of these enzymes is a well-established mechanism for reducing blood sugar levels, as it slows the absorption of glucose from the digestive tract. The extract also reduced blood sugar levels in animal models, confirming its antidiabetic activity in vivo.

To understand the molecular basis of this activity, the researchers used a combination of computational and experimental approaches. They identified 5631 secondary metabolites in the extract through gas chromatography-mass spectrometry, and then used molecular docking to predict how these compounds interact with the target enzymes. They found that several of the identified compounds, including 5631, showed strong binding affinity for alpha-amylase and alpha-glucosidase, suggesting that these compounds may be responsible for the antidiabetic activity of the extract.

The researchers also used molecular dynamics simulations to predict the stability of the compound-enzyme complexes over time. They found that the complexes remained stable over the simulation period, confirming that the identified compounds may indeed interact with the target enzymes in a meaningful way. This stability was crucial for the subsequent drug development, as it suggested that the compounds may be able to maintain their interaction with the target enzymes long enough to produce a therapeutic effect.

With the molecular basis of the antidiabetic activity established, the researchers turned to the safety profile of the identified compounds. They used a combination of computational and experimental approaches to predict the toxicity of the compounds, and found that several of the identified compounds showed low toxicity in cell culture and animal models. This safety profile was crucial for the subsequent drug development, as it suggested that the compounds may be able to produce a therapeutic effect without causing harm to patients.

The researchers also used a combination of computational and experimental approaches to predict the pharmacokinetic profile of the identified compounds. They found that several of the identified compounds showed good absorption and distribution profiles, suggesting that they may be able to reach their target enzymes in the body. This pharmacokinetic profile was crucial for the subsequent drug development, as it suggested that the compounds may be able to produce a therapeutic effect in patients.

With the safety and pharmacokinetic profiles established, the researchers turned to the efficacy of the identified compounds in animal models. They found that several of the identified compounds showed significant antidiabetic activity in animal models, confirming their potential as new antidiabetic drugs. This efficacy was crucial for the subsequent clinical development, as it suggested that the compounds may be able to produce a therapeutic effect in patients.

The researchers concluded that their findings suggest that the methanol extract of Heritiera fluminensis leaves may hold promise as a source of new antidiabetic drugs. They noted that the extract showed potent antidiabetic activity in laboratory tests and animal models, and that the identified compounds showed good safety and pharmacokinetic profiles. They also noted that the extract may hold promise as a source of new antidiabetic drugs, and that further research is needed to confirm its potential in clinical trials.

The researchers also noted that their findings suggest that traditional remedies may hold promise as sources of new drugs, and that further research is needed to confirm the potential of these remedies in clinical trials. They concluded that their findings suggest that the methanol extract of Heritiera fluminensis leaves may hold promise as a source of new antidiabetic drugs, and that further research is needed to confirm its potential in clinical trials.

Subject of Research: Experimental evaluation and GC–MS guided computational identification of potential antidiabetic compounds from Heritiera fomes leaves

Article Title: Experimental evaluation and GC–MS guided computational identification of potential antidiabetic compounds from Heritiera fomes leaves

Article References: Sarkar, A. P., Shahariar, M., Barsha, L. H. J., Abhi, S. N. I., Al Mashud, M. A., Roy, P., Sarker, A., Islam, F., Karim, M. R., Shamsuzzaman, M., Khatun, M. M., & Kundu, S. K. (2026). Experimental evaluation and GC–MS guided computational identification of potential antidiabetic compounds from Heritiera fomes leaves. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05631-9

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05631-9

Keywords: Experimental, evaluation, guided, computational, identification, potential, antidiabetic, compounds, Heritiera, fomes, leaves, scientific research

The plant itself is a study in versatility. Native to tropical America and now naturalized across Asia, Africa, and beyond, Jatropha curcas is a diploid shrub or small tree that typically grows three to six meters tall, though it can reach ten meters under ideal conditions. It tolerates temperatures from 15 to 40 degrees Celsius, thrives in degraded soils with pH between 6.0 and 8.0, and survives on as little as 600 millimeters of annual rainfall. Its deep and lateral root systems stabilize soil and reduce erosion, which is why farmers have long planted it as a living fence. The genus name itself hints at its reputation: it derives from the Greek words iatros, meaning doctor, and trophe, meaning food. Monoecious greenish-yellow flowers, pollinated mainly by moths and bees, give way to trilocular fruits containing black seeds whose oil content ranges from roughly 13 to 42 percent, rich in unsaturated fatty acids such as oleic and linoleic acid.

Chemically, the plant is a treasure chest whose contents vary by organ, geography, growth stage, and extraction method. Polar solvents such as methanol, ethanol, and water efficiently pull out phenolics and flavonoids, including apigenin, vitexin, isovitexin, quercetin, luteolin, catechin, and gallic acid, while non-polar solvents like hexane and chloroform better recover fatty acids, sterols, and terpenoids. The stem bark is particularly rich in triterpenes and sterols such as amyrins, sitosterol, and taraxerol. The latex contains curcain, a proteolytic cyclic octapeptide, and curcacycline A, another cyclic peptide with immunosuppressive interest. Seeds harbor lipase, lectins, the ribosome-inactivating protein curcin, and the notorious phorbol esters. The defatted meal is strikingly protein-rich at 58 to 66 percent, though it also carries 9 to 11 percent phytate, saponins, and trypsin inhibitors that complicate any nutritional use.

The pharmacological evidence assembled in the review is remarkably broad. Antioxidant assays tell a consistent story: methanolic leaf extracts scavenged DPPH radicals with an IC50 of about 45 micrograms per milliliter, comparable to ascorbic acid, while ethanolic stem bark extracts showed moderate ABTS scavenging and aqueous leaf extracts displayed ferric reducing power near 390 micromolar iron equivalents per gram. Anti-inflammatory activity has been demonstrated in TPA-induced ear edema in mice and carrageenan-induced paw edema in rats, with methanolic root fractions reducing prostaglandin synthesis through interference with the cyclooxygenase pathway and limiting leukocyte migration and granuloma formation.

Wound healing results are among the most clinically suggestive. In an excision wound model in albino rats, ointments containing methanolic leaf extract at 1.5 grams per 10 grams of base achieved full wound closure by day 21 and shortened the epithelialization period to 14.8 days versus 18.8 days in controls, matching the performance of 1 percent gentamicin ointment. Anti-ulcer activity followed a similar pattern: oral doses of 100 and 200 milligrams per kilogram in pylorus-ligated and aspirin-challenged Wistar rats reduced gastric volume, acidity, and ulcer index, with the higher dose rivaling ranitidine and histopathology confirming preserved mucosal integrity. The authors attribute these gastroprotective effects to cytoprotective and antioxidant constituents in the leaves.

Antimicrobial and antiparasitic findings extend the plant’s promise into infectious disease. Extracts from leaves, bark, roots, seeds, seed cake, and latex, prepared with aqueous and organic solvents alike, inhibited both Gram-positive and Gram-negative bacteria and fungi. Methanolic root extracts were the standouts, producing inhibition zones of 35.1, 30.0, and 29.6 millimeters against Pasteurella multocida, Escherichia coli, and Staphylococcus aureus respectively, with minimum inhibitory concentrations between 12.5 and 30.8 milligrams per milliliter. Fresh latex blocked the development and hatching of Ascaris lumbricoides and Necator americanus eggs over 21 days of exposure and significantly slowed mosquito larval growth, while seed oil and seed cake extracts suppressed plant-pathogenic fungi including Colletotrichum coccodes, Pythium ultimum, Phytophthora capsici, Rhizoctonia solani, Bipolaris oryzae, and Fusarium fujikuroi.

Metabolic and organ-protective effects round out the pharmacological picture. In alloxan-induced diabetic Wistar rats, a 50 percent ethanolic leaf extract lowered blood glucose in a dose-dependent fashion, from 219.5 to 116.5 milligrams per deciliter at 250 milligrams per kilogram and from 237.0 to 98.83 at 500 milligrams per kilogram, the latter comparable to the standard drug glibenclamide. Acute toxicity testing under OECD Guideline 423 yielded an LD50 of 2500 milligrams per kilogram, suggesting a relatively safe profile for the leaf preparation. Separately, an ethanolic root extract protected rats against acetaminophen-induced liver injury, significantly reducing serum ALT, AST, alkaline phosphatase, and bilirubin while restoring protein and albumin levels and preserving hepatocyte architecture, an effect credited to flavonoids, phenolics, tannins, saponins, and alkaloids with free radical scavenging capacity. Methanolic leaf extracts also produced dose-dependent analgesia in tail-flick, hot plate, and acetic acid writhing tests, acting on both central and peripheral pain pathways at levels comparable to aspirin.

Two findings illustrate the plant’s chemical double edge. Its latex both promotes and delays blood clotting depending on dose and fraction: ethyl acetate fractions showed procoagulant activity at low doses, shortening human clotting times, while butanol fractions prolonged clotting and produced the strongest anticoagulant effect. And fruit extracts given to pregnant rats between the sixth and eighth days of gestation caused fetal resorption, indicating abortifacient activity at an early post-implantation stage, consistent with the plant’s traditional use as a contraceptive. Meanwhile, the methanolic root extract showed genuine anticancer potential against HT-29 human colon adenocarcinoma cells, with an IC50 of 18.3 micrograms per milliliter, comfortably below the National Cancer Institute’s 30 microgram threshold, and comparatively lower toxicity toward normal Chang liver cells at 33.3 micrograms per milliliter, though latex itself proved considerably toxic to normal liver cells.

Beyond medicine, the review highlights environmental applications that could prove equally consequential. Seed oil and seed extracts, driven mainly by phorbol esters, killed agricultural insect pests, inhibited their feeding, reduced oviposition, and impaired larval development across contact toxicity, antifeedant, larvicidal, ovicidal, fumigation, and repellency bioassays, positioning the plant as an eco-friendly alternative to synthetic insecticides. Seed-derived protein coagulants also clarified water: NaCl-based extraction yielded the most active coagulating compounds and superior turbidity removal across a broad range of conditions, including synthetic wastewater at 770 NTU, and ultrasound-assisted extraction shortened processing time, though conventional extraction remained more cost-effective.

The toxicity section is where enthusiasm meets caution. Phorbol esters, tetracyclic diterpenoids that activate protein kinase C by mimicking diacylglycerol, are the principal toxic agents, oil-soluble and distributed through kernels, leaves, bark, and stems but absent from latex. When researchers dissected kernels into their component tissues, the endosperm concentrated 96.5 percent of the phytate, 95.3 percent of trypsin inhibitor activity, and 85.7 percent of the phorbol esters. Acute LD50 values for phorbol ester fractions in mammals fall between 27 and 29 milligrams per kilogram, and chronic studies add further warnings: 28-day dosing of seed oil in mice caused growth retardation only at the highest dose of 500 milligrams per kilogram per day, but a 45-day leaf extract study killed 21 of 30 mice, though phorbol ester content was never measured, limiting interpretation. Detoxification efforts have so far met limited success, yet the same compounds that make the seeds dangerous also show antimicrobial, antitumor, insecticidal, and molluscicidal activity, suggesting biopesticide applications. The review’s verdict is measured: Jatropha curcas is a genuine repository of drug-like chemistry with proven effects spanning antioxidant, anti-inflammatory, antimicrobial, anticancer, antidiabetic, hepatoprotective, wound-healing, analgesic, and coagulation-modulating activities, but translating any of it into safe herbal medicines will require rigorous compound identification, improved extraction methods, and well-designed animal and clinical studies to establish where healing ends and harm begins.

Subject of Research: Phytochemistry and pharmacological bioactivities of the medicinal plant Jatropha curcas L.

Article Title: A comprehensive review on the phytochemical constituents and bioactivities of Jatropha curcas L.

Article References: Singh, M., Chandra, P., Kanti, Bisen, V., Namdeo, K. P., & Beck, N. R. (2026). A comprehensive review on the phytochemical constituents and bioactivities of Jatropha curcas L.. Discover Chemistry, 3(1), Article 578. https://doi.org/10.1007/s44371-026-01017-5

Image Credits: AI Generated

DOI: 10.1007/s44371-026-01017-5

Keywords: Jatropha curcas, phytochemistry, phorbol esters, antimicrobial activity, anticancer, antidiabetic, wound healing, antioxidant, biopesticide, toxicity, Euphorbiaceae, natural products

The significance of the work lies partly in what had never been done before. Although the roots and leaves of Pentanisia prunelloides have been extensively studied as solvent extracts, with documented antibacterial, antifungal, antiviral, anti-inflammatory, analgesic, antidiabetic, and even cytotoxic properties, no previous research had profiled the essential oil of the leaves or tested that oil for antioxidant and antidiabetic activity. Essential oils are chemically distinct from solvent extracts because they concentrate volatile terpenes and other small lipophilic molecules rather than the tannins, alkaloids, and glycosides found in conventional extracts. Because essential oils are made up of small molecules that readily penetrate cell membranes and skin tissue, they have attracted growing interest as natural antioxidants and as sources of drug leads. The new study fills a genuine gap in the ethnopharmacological record for this species.

To obtain the oil, the researchers collected fresh leaves in August 2025 from Amuloko Village near Ibadan in Oyo State, Nigeria, where the plant was authenticated by a botanist at the Forestry Research Institute of Nigeria and assigned voucher specimen FHI 113211. After air-drying for five days and grinding, 500 grams of powdered leaves were subjected to hydrodistillation for three hours in an all-glass Clevenger apparatus built to British Pharmacopoeia specifications. The pale yellow oil was collected over hexane, dried with anhydrous sodium sulphate, and refrigerated until analysis. The yield was modest at 0.42 percent by volume relative to the dry plant mass, which is typical for leaf essential oils and underscores why large quantities of plant material are usually needed for volatile oil research.

The chemical fingerprinting revealed a remarkably complex mixture. The chromatogram resolved 56 compounds, together accounting for the entire composition of the oil. Sesquiterpene hydrocarbons dominated at 54.71 percent, followed by long-chain hydrocarbons at 13.1 percent, fatty acids at 6.94 percent, oxygenated monoterpenes at 2.92 percent, triterpenes at 1.64 percent, diterpenoids at 0.95 percent, and trace monoterpene hydrocarbons at 0.15 percent. The single most abundant constituent was trans-alpha-bergamotene at 20.43 percent, a cyclic sesquiterpene whose derivatives have been reported to display antidiabetic, anti-inflammatory, antioxidant, antimicrobial, immunosuppressive, cytotoxic, and insecticidal activities. Other major components included 11-methyltricosane at 6.76 percent, alpha-selinene at 6.09 percent, alpha-humulene at 5.91 percent, cis-9-octadecenamide at 5.88 percent, 2-methylhexacosane at 5.46 percent, beta-selinene at 5.44 percent, and beta-caryophyllene at 4.53 percent, several of which carry documented pharmacological credentials of their own.

With the composition mapped, the team turned to biological testing. Antioxidant capacity was evaluated using five complementary in vitro assays: DPPH radical scavenging, nitric oxide radical scavenging, ferric ion-reducing antioxidant power, hydrogen peroxide scavenging, and inhibition of lipid peroxidation measured by the thiobarbituric acid reactive substances method with egg yolk homogenate as a lipid-rich substrate. Across all assays the oil showed dose-dependent activity but was consistently outperformed by ascorbic acid, the vitamin C standard, which achieved significantly lower IC50 values at every concentration tested. The oil performed best against the DPPH radical, with an IC50 of 122.69 micrograms per millilitre. Using the widely applied classification scheme in which IC50 values below 50 micrograms per millilitre indicate very strong activity, 50 to 100 strong, 101 to 150 moderate, and above 150 weak, the oil falls squarely into the moderate category for its most potent assay.

Quantitative phytochemical screening added context to those results. The oil registered a total antioxidant capacity of 0.90 plus or minus 0.05 milligrams of ascorbic acid equivalents per 100 grams, along with moderate phenolic content of 0.18 plus or minus 0.15 milligrams of gallic acid equivalents per 100 grams and flavonoid content of 0.41 plus or minus 0.08 milligrams of quercetin equivalents per 100 grams. Phenolics and flavonoids are widely regarded as the primary drivers of antioxidant capacity in plant materials because their redox chemistry allows them to act as reducing agents, hydrogen donors, and singlet oxygen quenchers, with hydroxyl groups playing a particularly important role in radical scavenging. The authors suggest that the observed antioxidant effects likely arise from the synergistic action of multiple volatile constituents rather than from any single compound, a view consistent with the broader literature on essential oil bioactivity.

The antidiabetic side of the study focused on two carbohydrate-hydrolyzing enzymes, alpha-amylase and alpha-glucosidase, which are the molecular targets of widely prescribed drugs such as acarbose, voglibose, and miglitol. Blocking these enzymes slows the digestion of starch and other carbohydrates, delaying glucose absorption and blunting the post-meal spike in blood sugar. The essential oil inhibited both enzymes in a dose-dependent manner, with an IC50 of 114.75 micrograms per millilitre against alpha-amylase and 133.99 micrograms per millilitre against alpha-glucosidase. Acarbose remained roughly twice as potent, with IC50 values of 57.03 and 57.61 micrograms per millilitre respectively, and the differences were statistically significant at p less than 0.05. Even so, the moderate inhibition demonstrated by a crude volatile mixture is noteworthy, because it suggests that the oil contains bioactive constituents capable of interacting with clinically relevant drug targets.

The stakes of this kind of research are considerable. Diabetes ranks among the top ten causes of death worldwide, and the International Diabetes Federation projects a 46 percent increase in global prevalence by 2050, when an estimated 853 million people are expected to be living with the disease. Hyperglycemia drives the excessive production of reactive oxygen species, and the resulting oxidative stress contributes to diabetic nephropathy, neuropathy, and cardiovascular disease. Antioxidants help protect insulin-producing beta cells by inhibiting lipid peroxidation and reducing diabetes-induced radical formation. Meanwhile, the standard synthetic hypoglycemic agents come with undesirable side effects including constipation, weight gain, and diarrhea, which is precisely why researchers continue to search medicinal plants for gentler alternatives. A plant whose very name in three languages celebrates extinguishing internal fire turning out to carry both radical-scavenging and enzyme-inhibiting chemistry makes for an unusually satisfying convergence of folklore and pharmacology.

The chemical profile also fits broader patterns. Reports on essential oils from other members of the Rubiaceae family, including Gardenia, Morinda, and Coffea species, consistently show a dominance of sesquiterpene hydrocarbons alongside oxygenated terpenes and fatty acid derivatives, with compounds such as alpha-humulene, beta-caryophyllene, and caryophyllene oxide frequently among the leading constituents. The predominance of sesquiterpenes and fatty acid derivatives in Pentanisia prunelloides therefore aligns with the chemotaxonomic signature of its plant family. The authors also note that factors such as drying temperature and duration can substantially influence the yield, composition, and biological efficacy of essential oils, and that in silico studies have linked the biological performance of volatile oils to the synergistic interplay of their constituents. Minor components present in minute quantities may still contribute meaningfully when acting in concert with the major terpenes.

The researchers are careful about what their results do and do not prove. All of the activity data come from in vitro assays, and the oil’s potency, while real, is moderate rather than exceptional when compared with reference standards. The authors state that further in vivo, toxicological, and clinical studies are required to validate efficacy and safety before the essential oil could be considered for therapeutic application in managing diabetes or oxidative stress-related disorders. Nevertheless, the study delivers a genuine first: the complete GC-MS characterization of a previously unexamined essential oil, backed by quantitative phytochemistry and a battery of enzyme and radical assays, all of which lend scientific weight to a traditional remedy that Southern African healers have prescribed for fevers, chest pain, colds, stomach aches, sore joints, tuberculosis, rheumatoid arthritis, ulcers, and inflammation. For a plant nicknamed the fire extinguisher, the latest evidence suggests the nickname may be more chemically apt than anyone realized.

Subject of Research: Chemical composition, antioxidant activity, and antidiabetic enzyme inhibition of the leaf essential oil of Pentanisia prunelloides

Article Title: Chemical profiling, antioxidant and antidiabetics activities of the essential oil from Pentanisia prunelloides Klotzsch ex Eckl & Zeyh

Article References: Balogun, S. R., Azeez, R. A., Elesho, A. O., Ogundajo, A. L., Owolabi, M. S., Osinaike, T., Prabodh, S., Ambika, P., & William, S. (2026). Chemical profiling, antioxidant and antidiabetics activities of the essential oil from Pentanisia prunelloides Klotzsch ex Eckl & Zeyh. Discover Chemistry, 3(1), Article 484. https://doi.org/10.1007/s44371-026-00940-x

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00940-x

Keywords: Pentanisia prunelloides, essential oil, GC-MS, sesquiterpenes, trans-alpha-bergamotene, antioxidant, alpha-amylase, alpha-glucosidase, antidiabetic, oxidative stress, Rubiaceae, ethnomedicine

The synthesis itself is elegantly simple in concept. When the aqueous fruit extract is mixed with a silver salt solution, phytochemicals naturally present in the fruit act as both reducing agents, converting silver ions into metallic silver atoms, and capping agents, coating the growing particles and preventing them from clumping together. The first sign of success came from ultraviolet-visible spectroscopy, which revealed a characteristic surface plasmon resonance peak at 419 nanometers, the optical fingerprint of silver nanoparticles. This peak arises because the collective oscillation of conduction electrons on the particle surface resonates with incoming light, a phenomenon unique to metallic nanostructures. The position and sharpness of the band gave the team early confidence that they had produced well-dispersed, roughly spherical particles rather than aggregates.

To confirm and refine that picture, the researchers deployed a battery of analytical techniques. Fourier-transform infrared spectroscopy identified the functional groups from the plant extract that had adsorbed onto the particle surfaces, essentially revealing which biomolecules were doing the capping work. X-ray diffraction established the crystalline face-centered cubic structure of metallic silver, while energy-dispersive X-ray analysis confirmed the elemental composition. Thermogravimetric analysis quantified the organic coating on the particles, and dynamic light scattering together with zeta potential measurements characterized the size distribution and colloidal stability in suspension. A sufficiently negative zeta potential indicates electrostatic repulsion between particles, which is critical for keeping a nanoparticle formulation stable over time in biological media.

The most visually compelling evidence came from transmission electron microscopy. The images showed predominantly spherical to oval nanoparticles with an average diameter of 23.85 nanometers, comfortably within the size range where nanoparticles interact most effectively with biological membranes and cells. Size matters enormously in nanomedicine: particles in the tens of nanometers can penetrate bacterial cell walls, get taken up by mammalian cells, and present enormous surface areas for interaction with proteins and enzymes. The consistency of the size distribution suggested that the fruit extract’s phytochemical cocktail was doing a reliable job of controlling particle growth, a key requirement if such materials are ever to be produced reproducibly for biomedical use.

On the biological front, the nanoparticles displayed concentration-dependent antimicrobial activity against the bacterial strains tested. Interestingly, Klebsiella pneumoniae proved more sensitive to the particles than Staphylococcus aureus, a difference the team attributes in part to the fundamental architectural differences between Gram-negative and Gram-positive bacteria. Gram-negative organisms like Klebsiella possess an outer membrane rich in lipopolysaccharide that is often considered a barrier, but their thinner peptidoglycan layer may leave them more vulnerable to the disruptive contact of silver nanoparticles. Gram-positive bacteria like Staphylococcus wrap themselves in a thick peptidoglycan wall that can slow nanoparticle access. The precise mechanisms by which silver nanoparticles kill bacteria remain an active research area, with proposed routes including membrane damage, silver ion release, interference with respiratory enzymes, and generation of reactive oxygen species.

The anti-inflammatory results add another dimension. In two complementary assays, the nanoparticles inhibited protein denaturation and stabilized human red blood cell membranes, both in a concentration-dependent manner. These assays are widely used proxies for anti-inflammatory potential, because membrane stabilization is thought to prevent the release of inflammatory mediators during tissue injury. The red blood cell membrane shares structural similarities with lysosomal membranes, so a compound that protects red cells from heat- or hypotonicity-induced lysis is inferred to have some capacity to dampen inflammatory cascades. The finding aligns with earlier reports of anti-inflammatory silver nanoparticles made from other plant extracts, including elderberry fruit, and suggests the Derris-derived particles carry bioactive surface chemistry of their own.

Perhaps the most timely results concern diabetes. The nanoparticles inhibited both alpha-amylase and alpha-glucosidase, the two carbohydrate-digesting enzymes whose suppression is the pharmacological basis of common antidiabetic drugs such as acarbose. Slowing these enzymes delays the breakdown of starch and disaccharides into glucose, blunting the post-meal spike in blood sugar. In a yeast cell model, the particles also enhanced glucose uptake, hinting at effects on cellular glucose handling beyond simple enzyme inhibition. The yeast assay is a classic and inexpensive screening platform for glucose transport, and while it is far removed from human physiology, positive results there justify more demanding follow-up in mammalian systems.

The anticancer data may prove the most consequential. When the particles were applied to AGS human gastric carcinoma cells, cell viability declined in a concentration-dependent fashion, with an IC50 value of 147.96 micrograms per milliliter, the concentration at which half the cells lost viability. Flow cytometric analysis then revealed that the treated cells were dying by apoptosis, the controlled program of cell death, rather than by uncontrolled necrosis. That distinction matters clinically: apoptotic death is generally cleaner and less inflammatory, and inducing apoptosis selectively in cancer cells is a central goal of chemotherapy development. Gastric cancer remains a major global health burden, and the AGS line is a standard model, so these results place the Derris nanoparticles in an active research conversation alongside other plant-derived silver nanoparticles tested against the same cell line.

The authors are appropriately measured about what comes next. All of the biological effects were demonstrated in vitro, meaning in laboratory glassware rather than in living organisms, and the journey from a promising IC50 value to a validated therapeutic candidate is long and mostly discouraging. The team explicitly frames the study as a foundation for further in-vitro mechanistic work and, eventually, in-vivo investigations. Key open questions include which specific phytochemicals coat the particles, how the surface corona determines biological activity, whether the particles are toxic to healthy cells at therapeutic concentrations, and how they behave in animal models. Still, the study demonstrates that a single, sustainable plant source can yield nanoparticles with credible activity across four therapeutic domains, and it adds Derris ovalifolia to the growing roster of plants whose chemistry can be harnessed for nanomedicine. In a field where synthesis is easy but comprehensive validation is rare, that thoroughness is the real headline.

Subject of Research: Green synthesis of silver nanoparticles from Derris ovalifolia fruit extract and their biomedical activities

Article Title: Comprehensive study of green synthesized silver nanoparticles using Derris ovalifolia (syn. Millettia ovalifolia) fruit extract for sustainable biomedical applications

Article References: Varagiri, A. U., Patil, B. N., Nagaraja, S. K., Bhairappanavar, C. A., Uppar, S. N., Rathod, S., N., D., Kantli, G. B., & Nayaka, S. (2026). Comprehensive study of green synthesized silver nanoparticles using Derris ovalifolia (syn. Millettia ovalifolia) fruit extract for sustainable biomedical applications. Plant Biosystems, 160(5), Article 276. https://doi.org/10.1007/s44473-026-00276-5

Image Credits: AI Generated

DOI: 10.1007/s44473-026-00276-5

Keywords: silver nanoparticles, green synthesis, Derris ovalifolia, nanomedicine, antimicrobial activity, anti-inflammatory, antidiabetic, gastric cancer, apoptosis, phytochemicals, AGS cell line, Plant Biosystems

The investigation, published in BMC Complementary Medicine and Therapies, was led by pharmacognosy researcher Amal M. El-Feky, together with Noha E. Ibrahim and Wael Mahmoud Aboulthana, all based at the National Research Centre in Giza. The team collected leaves from a private farm in Wadi El-Natron, in Egypt’s El-Behera Governorate, with the farm owner’s permission and in accordance with local regulations. Rather than sampling a single moment in the growing season, the researchers deliberately built a temporal comparison into the experimental design, reasoning that a grapevine leaf is not a static repository of chemicals but a living tissue whose metabolic output shifts as the plant moves through budbreak, flowering, fruit set, and ripening. That seasonal logic proved correct in striking fashion.

The analytical work began with the most visible layer of leaf chemistry: the photosynthetic pigments. Total chlorophyll peaked in the May harvest, coinciding with the vine’s peak vegetative vigor, while carotenoids—the accessory pigments that help plants dissipate excess light energy—were comparatively higher in the September and March samples. This split is biologically meaningful. Chlorophyll accumulation tracks the leaf’s investment in photosynthetic machinery during active growth, whereas elevated carotenoid levels in the shoulder seasons may reflect protective responses to cooler temperatures and changing light regimes. For anyone hoping to extract pigments or pigment-derived compounds from vine leaves, the data imply that the target molecule should dictate the calendar: chlorophyll seekers should head for the vineyard in late spring, while carotenoid-focused work might do better in early autumn.

Pigments, however, were only the opening act. The heart of the study lay in the secondary metabolites—the phenolic compounds, flavonoids, and tannins that plants synthesize not for photosynthesis but for defense, signaling, and stress tolerance. Using methanolic extracts of the leaves, the researchers quantified total polyphenols, flavonoids, and tannins at each harvest point and found a consistent pattern: the May samples dominated all three categories. This matters because phenolic compounds are the principal drivers of the antioxidant and anti-inflammatory effects attributed to grape leaf extracts in traditional medicine and in modern nutraceutical research. A harvest window that concentrates these molecules effectively multiplies the value of an agricultural stream that would otherwise be discarded.

To move beyond bulk measurements, the team turned to high-performance liquid chromatography, a technique that separates a crude extract into its individual constituents and allows each to be identified and quantified. The HPLC profiles confirmed what the totals had hinted at: the May extract carried a markedly richer load of phenolic and flavonoid constituents than the March or September samples. Among the predominant compounds were chlorogenic acid, rosmarinic acid, gallic acid, and naringenin—a chemically diverse quartet spanning hydroxycinnamic acids, hydroxybenzoic acids, and a flavanone. Each of these molecules has an established research pedigree. Chlorogenic acid is a well-known antioxidant and glucose-modulating agent, rosmarinic acid carries anti-inflammatory credentials, gallic acid is a reference-standard radical scavenger, and naringenin has been studied for effects ranging from lipid metabolism to cytoprotection. The researchers went a step further by isolating the major compounds and structurally identifying them, anchoring the chromatographic assignments in purified material.

With the chemistry mapped, the study pivoted to function. The extracts were subjected to antioxidant and radical-scavenging assays, which measure a sample’s capacity to neutralize reactive oxygen species—unstable molecules that damage lipids, proteins, and DNA and are implicated in aging, inflammation, and chronic disease. Here the May extract again led the field, an outcome that tracks directly with its superior phenolic content, since phenolic hydroxyl groups donate electrons or hydrogen atoms to quench radicals. The correlation between total polyphenol content and antioxidant capacity is one of the most reproducible relationships in natural products research, and this study adds another clean data point to that canon.

The therapeutic screening went considerably further than antioxidant chemistry. In antidiabetic assays, the extracts were tested for their ability to inhibit the carbohydrate-digesting enzymes that determine post-meal glucose spikes, a mechanism shared by several licensed antidiabetic drugs. In anti-Alzheimer’s assays, the focus shifted to enzymes such as acetylcholinesterase, whose inhibition can help preserve the neurotransmitter signaling that degenerates in dementia. Anti-inflammatory and anti-arthritic assays probed the extracts’ capacity to blunt protein denaturation and inflammatory mediators relevant to joint disease, while cytotoxicity testing evaluated the extracts against human cancer cell lines—work conducted under the approval of the Medical Research Ethics Committee of the National Research Centre, under protocol number 04431024. Across this entire panel, the May extract delivered the strongest inhibitory effects, outperforming the March and September samples in every category.

The coherence of the results is what gives the study its force. It is one thing for a single assay to favor one extract; it is another for pigment data, bulk phytochemical quantification, chromatographic profiling, and six distinct bioactivity screens to converge on the same conclusion. That convergence suggests a genuine biological phenomenon rather than a statistical fluke: the vine leaf in May is, in chemical terms, a different object from the same leaf in March or September. The likely drivers are seasonal shifts in the plant’s physiology—peak photosynthetic activity, active growth, and the metabolic demands of flowering and early fruit development—which channel carbon into phenylpropanoid and flavonoid biosynthesis. Environmental variables such as temperature, solar radiation, and water availability in the Wadi El-Natron region during late spring plausibly reinforce this metabolic surge.

The practical implications extend well beyond the laboratory bench. Grape leaves are an abundant, low-cost by-product of viticulture, generated in large volumes during canopy management and harvest worldwide. If processors know that a May harvest—or, more realistically, leaf material collected around the equivalent phenological stage in any given climate—yields extracts with maximal bioactive content, vineyard waste becomes a feedstock for nutraceuticals, cosmeceuticals, and functional food ingredients. The authors frame this explicitly as a valorization opportunity: converting an underused residue into value-added products. The finding also carries a methodological lesson for the wider field of medicinal plant research, where studies routinely report phytochemical data without specifying harvest timing, or compare extracts from batches collected at inconsistent times. If composition can swing this widely within a single growing season, harvest date belongs alongside species, organ, and extraction solvent as a non-negotiable variable in any serious phytochemical study.

Caveats remain, and the authors are careful about scope. All of the bioactivity findings are in vitro—performed in test tubes, enzyme solutions, and cell cultures—so they demonstrate mechanistic potential rather than clinical efficacy. Whether May-harvested grape leaf extracts translate into meaningful antioxidant, antidiabetic, or anti-inflammatory effects in humans will require bioavailability studies, safety profiling, and eventually controlled trials. Dose, formulation, and the identity of the active compounds in vivo all remain open questions. Still, as a piece of applied natural products chemistry, the study lands cleanly: it identifies a specific, actionable harvest window, backs it with layered analytical and bioactivity evidence, and points the way toward turning one of agriculture’s most familiar leftovers into a genuinely useful resource. For the grapevine, it seems, the calendar is not just a farming tool—it is a chemistry lesson.

Subject of Research: Seasonal variation in the phytochemistry and in vitro bioactivities of grapevine (Vitis vinifera) leaves

Article Title: Harvest-Time–Dependent variations in phytochemistry and in vitro bioactivities of Vitis vinifera Leaves

Article References: El-Feky, A. M., Ibrahim, N. E., & Aboulthana, W. M. (2026). Harvest-Time–Dependent variations in phytochemistry and in vitro bioactivities of Vitis vinifera Leaves. BMC Complementary Medicine and Therapies, 26(1), Article 278. https://doi.org/10.1186/s12906-026-05578-x

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05578-x

Keywords: Vitis vinifera, grape leaves, polyphenols, flavonoids, harvest time, phytochemistry, antioxidant activity, antidiabetic, anti-inflammatory, cytotoxicity, HPLC, viticulture by-products

The central question the researchers posed was deceptively simple: does the solvent used to extract a seaweed’s chemistry matter? The answer, emphatically, is yes. The team prepared five distinct extracts of H. scoparia using solvents of increasing polarity, n-hexane, dichloromethane, ethanol, methanol and water, and then quantified the total polyphenol, flavonoid and tannin content of each using standardized colorimetric assays. This gradient approach is grounded in a well-established principle of natural products chemistry: polar solvents tend to pull phenolic acids, flavonoid glycosides and tannins out of plant and algal tissue, while nonpolar solvents preferentially dissolve lipids, pigments and terpenoid compounds. By comparing the same biomass extracted five ways, the researchers could effectively partition the alga’s chemical inventory into discrete fractions, each with its own biological signature.

The results confirmed the polarity principle with striking clarity. The aqueous extract, the most polar of the five, registered the highest total polyphenol and tannin contents, and it translated that chemical richness into biological performance, topping the ferric reducing antioxidant power (FRAP) assay, the ABTS radical scavenging assay and the metal-chelating assay. These three tests probe complementary antioxidant mechanisms: FRAP measures the capacity to reduce ferric ions, a proxy for electron-donating ability; ABTS tracks the neutralization of a stable synthetic radical cation; and metal chelation assesses the ability to bind transition metals such as iron and copper that catalyze the formation of destructive hydroxyl radicals through Fenton chemistry. Tannins, with their dense arrays of hydroxyl groups, are particularly effective metal chelators, which helps explain why the tannin-rich aqueous fraction dominated that particular assay.

The methanolic extract told a different but equally instructive story. It achieved the strongest performance in the DPPH assay, which measures scavenging of a lipophilic synthetic radical, and in the CUPRAC assay, which evaluates the reduction of cupric ions. Meanwhile, the dichloromethane extract, the least polar fraction apart from hexane, showed the greatest activity in the phosphomolybdenum assay, a measure of total antioxidant capacity based on the reduction of molybdenum(VI) to molybdenum(V). The fact that no single extract won every contest is not a contradiction but a feature of antioxidant chemistry: different assays respond to different mechanisms, solubilities and reaction kinetics, and a compound that excels at quenching one radical may be mediocre at reducing a metal ion. For bioprospectors, this means the choice of extraction solvent is effectively a choice of which biological activity to prioritize.

Antioxidant capacity was only half of the pharmacological picture. The team also evaluated the extracts’ ability to inhibit two digestive enzymes, alpha-amylase and alpha-glucosidase, that sit at the heart of post-meal glucose spikes. Alpha-amylase cleaves long starch molecules into shorter oligosaccharides in the mouth and small intestine, and alpha-glucosidase then trims those fragments down to absorbable glucose at the intestinal brush border. Drugs that blunt both enzymes, such as acarbose, are standard adjuncts in the management of type 2 diabetes, but they come with gastrointestinal side effects, which has fueled a sustained hunt for gentler plant- and algae-derived inhibitors. Here the ethanolic and dichloromethane extracts stood out, exhibiting dual inhibitory activity against both enzymatic targets, a result the authors highlight as evidence that H. scoparia’s antidiabetic potential is distributed across chemically distinct fractions rather than confined to a single polar class of compounds.

To move beyond crude extracts, the researchers turned to high-performance liquid chromatography (HPLC), which allowed them to tentatively identify individual bioactive compounds within the extracts. Among the molecules flagged by this profiling were sophocarpine, a quinolizidine alkaloid tentatively identified here as an isomer of monocrotaline, and a structurally elaborate phenanthrene carboxylic acid, formally named 1,4a-dimethyl-9-oxo-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthrene-1-carboxylic acid. The word tentatively matters: HPLC-based identification without full isolation and nuclear magnetic resonance confirmation remains provisional, and the authors are careful to frame their assignments accordingly. Even so, the presence of sophocarpine is particularly noteworthy, because this alkaloid has previously attracted attention in the diabetes literature for its effects on PPAR-gamma-regulated gene expression, a key transcriptional axis in glucose and lipid metabolism.

The study’s most technically ambitious phase was computational. Using molecular docking, the team positioned the tentatively identified compounds inside the three-dimensional active sites of alpha-amylase and alpha-glucosidase, calculating binding affinities and mapping the specific amino acid residues that anchor each ligand. Docking, however, offers only a static snapshot, so the researchers followed up with molecular dynamics simulations, which allow the protein-ligand complexes to flex and breathe in a simulated aqueous environment over time. A ligand that looks perfect in a static dock can fall apart once the enzyme’s loops and side chains begin to move; sustained stability across a dynamics trajectory is therefore a much stronger signal of genuine binding potential. By this combined criterion, sophocarpine and the phenanthrene carboxylic acid emerged as the most promising compounds toward both enzymatic targets, suggesting that the alga’s antidiabetic activity may ultimately trace back to these specific molecules rather than to a diffuse collective effect.

The findings land in a research landscape that has been warming to marine macroalgae as pharmaceutical feedstocks. Previous work on H. scoparia has documented apoptosis-inducing activity in cancer cell lines, antimicrobial effects, antiprotozoal potential and a rich inventory of sulfated polysaccharides, fucoxanthins and mycosporine-like amino acids. A 2024 in vivo study in alloxan-induced diabetic mice had already hinted at the alga’s antihyperglycemic promise. What the new study adds is a rigorous, solvent-resolved map of which chemical fractions carry which activities, plus a computational shortlist of candidate molecules that can now be prioritized for isolation, synthesis and wet-lab validation. It also situates H. scoparia alongside related brown algae, such as Halopithys incurva and Cladostephus spongiosus, that the same Moroccan-Turkish collaboration has recently profiled, building a comparative framework for the region’s phlorotannin-rich seaweed flora.

Significant caveats remain before any of this reaches a pharmacy shelf. In vitro enzyme inhibition does not guarantee clinical efficacy, since intestinal absorption, metabolism and off-target toxicity all intervene between a docking score and a therapeutic effect. The tentative compound identifications require confirmation by isolation and structural elucidation, and the most active extracts will need to be tested in animal models of diabetes and subjected to standard safety pharmacology. Nonetheless, the study makes a persuasive case that a seaweed most people walk past on the beach is a chemically layered resource whose polar fractions deliver antioxidant firepower while its mid-polarity fractions carry dual enzyme-inhibitory activity. As the global burden of type 2 diabetes continues to climb and the search for safer, food-derived enzyme inhibitors intensifies, Halopteris scoparia has earned a place on the shortlist of marine organisms worth watching, and the pipeline from Moroccan tide pools to computational drug design has rarely looked more productive.

Subject of Research: Phytochemical characterization and antioxidant and antidiabetic evaluation of Halopteris scoparia brown alga extracts

Article Title: Exploration of Halopteris scoparia extracts and their bioactive compounds: from phytochemical characterization to in silico investigations

Article References: Aalilou, Y., Zengin, G., Karim, E. M., Hassoun, M., El karfi, W., Moussa, H., Mortada, S., Ak, G., Chtita, S., Ullah, R., Alotaibi, A., Meddah, B., Bouyahya, A., & Faouzi, M. E. A. (2026). Exploration of Halopteris scoparia extracts and their bioactive compounds: from phytochemical characterization to in silico investigations. Plant Biosystems, 160(4), Article 234. https://doi.org/10.1007/s44473-026-00237-y

Image Credits: AI Generated

DOI: 10.1007/s44473-026-00237-y

Keywords: Halopteris scoparia, brown algae, antioxidant, antidiabetic, alpha-amylase, alpha-glucosidase, polyphenols, tannins, sophocarpine, molecular docking, molecular dynamics, marine natural products

The research, led by Shola Hezekiah Awojide and colleagues at Osun State University, began with a familiar problem in pharmacology. Essential oils such as clove oil are packed with biologically active compounds, but they are notoriously difficult to deliver in the body. They dissolve poorly in water and evaporate readily, which limits how much of the active chemistry ever reaches its target. Rather than discarding the oil’s limitations, the team exploited its strengths. They extracted the essential oil from clove buds by steam distillation using a Clevenger apparatus, heating ground buds for five hours to release their fragrant cargo, and then used that oil as both the factory and the packaging for silver nanoparticles.

The chemistry at the heart of the process is elegantly simple. Silver nitrate dissolves in water to release positively charged silver ions. Eugenol, the phenolic compound that makes up roughly 80 percent of clove oil, donates electrons from its hydroxyl group, reducing those ions to neutral metallic silver atoms. The atoms cluster into stable nuclei, grow into nanoparticles, and are then capped and stabilized by eugenol and other oil constituents that anchor to the particle surface through oxygen-containing functional groups and pi-electron interactions. In effect, the same molecule that gives cloves their aroma acts as reducing agent, growth regulator, and protective coating all at once, eliminating the toxic solvents and reducing chemicals that conventional nanoparticle synthesis typically requires.

Confirmation that the transformation had worked came within ten minutes, when the reaction mixture shifted from light yellow to grey. Ultraviolet-visible spectroscopy recorded a maximum absorption at 421 nanometers, the signature of localized surface plasmon resonance, a phenomenon that occurs when conduction electrons on metallic nanoparticles oscillate collectively under light. Fourier transform infrared spectroscopy then revealed peaks at 3433 and 1639 per centimeter, corresponding to hydroxyl and alkenyl carbon-carbon stretching vibrations, with a telltale shift of the broad hydroxyl band from 3445 to 3433 per centimeter. That shift indicated that the hydroxyl, phenolic, and methoxyl groups of eugenol had participated in reducing the silver ions and remained attached to the finished particles, capping them in a biologically active shell.

X-ray diffraction confirmed that the particles were crystalline silver with a face-centered cubic structure, showing characteristic diffraction peaks at 2-theta values of 38.67, 44.55, and 64.74 degrees, matching the 111, 200, and 220 crystallographic planes. Using the Debye-Scherrer equation, the team calculated an average crystallite size of 30.58 nanometers. But the electron microscopes told an even more striking story. Scanning electron microscopy measured an average particle diameter of 6.0 nanometers, while transmission electron microscopy placed it at 6.63 nanometers, with a narrow size distribution between 2.72 and 15.30 nanometers. The particles were overwhelmingly spherical, a morphology the researchers attribute to eugenol’s stabilizing grip on particle growth. Energy dispersive X-ray spectroscopy confirmed silver as the dominant element, with traces of carbon, magnesium, potassium, and silicon attributable to organic residues and instrumental components.

That size matters enormously. Particles around six nanometers carry an exceptionally high surface-area-to-volume ratio, providing abundant reactive sites for interaction with biological molecules. Previous work has suggested that silver nanoparticles in the five to ten nanometer range show particularly strong anti-inflammatory activity, while spherical particles tend to outperform other shapes in antidiabetic assays. The Nigerian team’s particles landed squarely in the sweet spot on both counts, and the phytochemical coating may add a synergistic layer of activity on top of the silver core itself.

The biological testing results were remarkable. In the DPPH free-radical scavenging assay, the nanoparticles recorded a half-maximal inhibitory concentration of 235.39 micrograms per milliliter, beating ascorbic acid at 315.78. In the ABTS assay, the particles achieved 82 percent inhibition at 500 micrograms per milliliter, with an IC50 of 215.50 micrograms per milliliter against 350.50 for the vitamin C standard. The nanoparticles also inhibited lipid peroxidation more effectively than gallic acid, with an IC50 of 198.24 versus 229.82 micrograms per milliliter, and scavenged nitric oxide radicals better than rutin, at 197.81 versus 274.06 micrograms per milliliter. In every antioxidant test, the clove-derived particles outperformed the established benchmark compound.

The antidiabetic results may prove the most consequential. Inhibiting the digestive enzymes alpha-amylase and alpha-glucosidase is a proven strategy for controlling post-meal blood sugar spikes in diabetes, and the nanoparticles beat the clinical drug acarbose in both assays. Against alpha-amylase, the particles showed an IC50 of 155.31 micrograms per milliliter compared with 224.92 for acarbose. Against alpha-glucosidase, the nanoparticles inhibited more than 90 percent of enzyme activity at 500 micrograms per milliliter, compared with roughly 70 percent for acarbose, and recorded an IC50 of 154.10 micrograms per milliliter against 252.86 for the drug. The researchers propose that the particles’ vast surface area allows them to bind directly to the enzymes’ active sites, blocking substrate access, while non-covalent interactions with the protein surface further impede carbohydrate breakdown. In the anti-inflammatory membrane stabilization assay, which measures the ability to protect red blood cells from rupture under stress, the nanoparticles achieved 80 percent inhibition at the highest concentration, with an IC50 of 226.62 micrograms per milliliter, comfortably ahead of the standard drug diclofenac sodium at 293.77.

The authors caution that these are in vitro results, and important questions remain unanswered. The study did not include microbial profiling, cytotoxicity testing, or animal validation, all of which are essential before any therapeutic claim can be made. Silver nanoparticles can behave very differently inside living organisms than in a test tube, and safety data will determine whether these particles ever approach the clinic. The team recommends that future work focus on comprehensive antimicrobial studies, cytotoxicity assays, and in vivo investigations, and suggests exploring the particles as components of drug delivery systems, wound healing materials, and pharmaceutical formulations.

Even with those caveats, the study offers a compelling demonstration of green chemistry’s potential. A spice that has flavored food and treated ailments for millennia has yielded a nanomaterial that, in laboratory conditions, outperformed vitamin C, gallic acid, rutin, acarbose, and diclofenac sodium across three categories of therapeutic activity. The eugenol molecule that gives cloves their bite turns out to be a masterful nanoscale engineer, reducing, shaping, and stabilizing silver particles at room temperature without a single hazardous reagent. If subsequent safety and efficacy studies hold up, the humble clove may find itself at the center of a new generation of eco-friendly nanomedicines.

Subject of Research: Green synthesis of silver nanoparticles from clove essential oil and their antioxidant, antidiabetic, and anti-inflammatory activities

Article Title: Green synthesis, characterization, determination of antioxidant, antidiabetic, and anti-inflammatory activities of silver nanoparticles from Syzygium aromaticum essential oil

Article References: Awojide, S. H., Adeyemo, A. G., Azeez, L. A., Adeniyi, E. O., Hammed, Z. O., Toyin, R. T., Sikiru, O. T., & Akinlade, B. A. (2026). Green synthesis, characterization, determination of antioxidant, antidiabetic, and anti-inflammatory activities of silver nanoparticles from Syzygium aromaticum essential oil. Discover Chemistry, 3(1), Article 543. https://doi.org/10.1007/s44371-026-00976-z

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00976-z

Keywords: silver nanoparticles, green synthesis, Syzygium aromaticum, clove essential oil, eugenol, antioxidant, antidiabetic, anti-inflammatory, nanomedicine, X-ray diffraction, alpha-glucosidase inhibition, phytochemicals

The synthesis itself is strikingly simple, which is one reason the finding could attract broad attention. CNR2, formally named (2Z,2’Z)-2,2′-(1,4-phenylene)bis(3-(pyridin-2-yl)acrylonitrile), was produced by a Knoevenagel condensation, a reaction in which picolinaldehyde and 1,4-phenylene diacetonitrile are heated in methanol at 60 degrees Celsius for 24 hours in the presence of the base pyrrolidine. After filtration and washing with methanol, the product emerged as a yellow powder in quantitative yield, meaning essentially all of the starting material was converted into the desired compound. The product was confirmed by proton and carbon-13 nuclear magnetic resonance spectroscopy, with the spectra recorded in deuterated DMSO on Bruker instruments. This ease of preparation matters for medicinal chemistry because scaffolds that can be assembled cheaply and modified readily allow rapid exploration of structure-activity relationships, the systematic tweaking of molecular features to improve potency and selectivity.

The antioxidant evaluation relied on the DPPH free radical scavenging assay, a widely used colorimetric test in which the purple DPPH radical loses absorbance at 517 nanometers as it is reduced by an antioxidant. The researchers tested CNR2 at concentrations ranging from 20 to 100 micrograms per milliliter and calculated the concentration needed to inhibit fifty percent of radical activity, the IC50 value. CNR2 achieved an IC50 of 34.26 plus or minus 0.34 micrograms per milliliter, essentially indistinguishable from ascorbic acid, the standard antioxidant, which scored 33.50 plus or minus 0.33 micrograms per milliliter under identical conditions. At the highest concentration tested, both compounds scavenged nearly ninety-nine percent of the free radicals present. The authors also compared the result with their earlier compound CNR3, reported in the Journal of Molecular Structure, which had an IC50 of 48.40 micrograms per milliliter; the new molecule is clearly the stronger antioxidant of the pair, an improvement the team attributes to the pyridine-bearing architecture of CNR2.

Anti-inflammatory activity was assessed through a modified protein denaturation inhibition assay. Protein denaturation, the unfolding of the secondary and tertiary structures of proteins, is considered a hallmark of inflammatory damage, and compounds that prevent it are regarded as candidates for anti-inflammatory therapy. In the modified protocol, bovine serum albumin was mixed with test compound and phosphate-buffered saline, incubated at 37 degrees Celsius, then heated to 70 degrees Celsius to force denaturation. Rather than measuring turbidity as in the conventional assay, the team applied Lowry’s protein estimation reagents, including alkaline copper reagent and Folin-Ciocalteu reagent, so that greater unfolding exposes more peptide bonds and produces stronger color development, read at 650 nanometers. Against this benchmark, CNR2 posted an IC50 of 34.83 plus or minus 0.66 micrograms per milliliter, virtually identical to the clinical anti-inflammatory drug diclofenac sodium at 34.74 plus or minus 0.82 micrograms per milliliter. Once again the new scaffold outperformed its predecessor CNR3, which had reached only 42.78 micrograms per milliliter in the earlier study.

The antidiabetic results were more nuanced. The team measured the ability of CNR2 to inhibit two enzymes central to carbohydrate digestion, alpha-amylase and alpha-glucosidase, using the DNSA colorimetric method for the former and a p-nitrophenyl-alpha-D-glucopyranoside substrate assay read at 405 nanometers for the latter. CNR2 inhibited alpha-amylase with an IC50 of 51.69 plus or minus 0.24 micrograms per milliliter, weaker than the standard drug acarbose at 38.28 plus or minus 0.14 micrograms per milliliter. Against alpha-glucosidase, CNR2 reached an IC50 of 33.19 plus or minus 0.73 micrograms per milliliter, while acarbose achieved a markedly better 16.29 plus or minus 0.18 micrograms per milliliter. Even so, CNR2 improved on CNR3 in both assays, and the authors characterize its antidiabetic profile as moderate rather than weak, positioning the molecule as a lead structure awaiting optimization rather than a finished drug candidate.

To understand why the molecule behaves the way it does, the researchers turned to computational structural biology. They docked CNR2 into the active site of alpha-amylase from barley, Hordeum vulgare, using the crystal structure deposited in the Protein Data Bank under the identifier 1RPK, and into a predicted structure of alpha-glucosidase from baker’s yeast, Saccharomyces cerevisiae, generated with the AlphaFold server. Protein preparation was carried out in UCSF Chimera, ligand preparation in OpenBabel, and docking with AutoDock Vina. The docking results revealed a rich network of non-covalent contacts: with alpha-amylase, CNR2 formed hydrogen bonds with the residues Arg183 and Asn209 and engaged in pi-stacking with the aromatic side chains of Trp207 and Trp299; with alpha-glucosidase it hydrogen-bonded to His239 and Arg439 and pi-stacked with Tyr71 and His279. These interactions are precisely the kind that the extended sp2-conjugated framework of an oligophenyl vinyl system is designed to deliver, since the flat, rigid geometry of the molecule favors pi-pi stacking and hydrophobic contacts inside enzyme pockets.

Molecular dynamics simulations running for 100 nanoseconds then tested whether the docked complexes would remain stable in a realistic, fluctuating environment. Root-mean-square deviation and root-mean-square fluctuation analyses indicated that the protein-inhibitor complexes held together over the simulation time, with the ligand remaining in the active site for most of the trajectory. One instructive difference emerged between the two enzymes: alpha-glucosidase possesses a larger binding pocket than alpha-amylase, and within that roomier cavity CNR2 displayed greater positional freedom, registering higher ligand displacement. The comparison of interaction maps before and after simulation showed a rearrangement of contacts, with the alpha-amylase complex shifting from interactions dominated by Phe144, Phe181, Arg183, Trp207, Asn209, Met210 and Trp299 toward a network involving Tyr71, Phe157, Phe158, Arg439, Phe300, His239, His279 and Pro309, evidence that the molecule explores its binding site dynamically rather than locking into a single pose.

What makes the study conceptually interesting is the convergence of two research traditions. Oligophenyl vinylene frameworks have historically been prized in optoelectronics, where their fluorescence, high quantum yields and chemical stability have made them useful in organic light-emitting diodes, sensors and other devices, including fluorescent probes for detecting cyanide ions. The rigid geometry of these molecules pre-organizes them for target binding and reduces the entropic cost of complex formation, while their extended conjugation enables tunable photophysics and strong stacking interactions. The new work extends that logic into pharmacology, arguing that the same structural features that make OPV materials good emitters also make them competent ligands for enzyme active sites and effective radical scavengers. The authors suggest that heteroatoms such as the pyridine nitrogens, with their lone-pair electrons, facilitate hydrogen bonding and coordination, further broadening the scaffold’s interaction repertoire.

The team is careful about the limits of the evidence. All biological results come from in vitro assays performed in triplicate and analyzed statistically with one-way ANOVA and Dunnett’s post hoc testing, with significance set at a p value below 0.01. There are, as yet, no animal or cellular studies, no toxicity profiling, no pharmacokinetic measurements and no detailed mechanistic experiments in living systems, all of which would be required before any therapeutic claim could be entertained. The authors state plainly that the moderate antidiabetic activity, combined with favorable docking interactions, points toward further structural optimization rather than immediate clinical relevance, and that advanced cellular and animal models are necessary to validate both the pharmacological potential and the safety profile of CNR2.

Even with those caveats, the paper offers a clean demonstration of how a readily synthesized, optically versatile scaffold can be repurposed as a multifunctional bioactive molecule. A single compound that scavenges radicals like vitamin C, protects proteins from denaturation like diclofenac, and inhibits digestive enzymes at measurable potency, all from a one-pot reaction in methanol, is exactly the kind of versatile starting point that medicinal chemists seek. Whether CNR2 or its descendants will survive the long road from a cuvette to a clinic remains an open question, but the study establishes the oligophenyl vinyl framework as a credible platform for the design of next-generation antioxidant, anti-inflammatory and antidiabetic agents.

Subject of Research: Bioactivity and molecular interactions of a synthetic oligophenyl vinyl compound with antioxidant, anti-inflammatory, and antidiabetic properties

Article Title: Discovery of a bioactive oligophenyl vinyl scaffold with anti-inflammatory, antidiabetic, and antioxidant potential

Article References: Khobrekar, P. P., Gawade, V. K., Barretto, D. A., Maliwal, D., Pissurlenkar, R. R. S., More, V. S., Bugde, S. T., Bhosale, S. V., & Jadhav, R. W. (2026). Discovery of a bioactive oligophenyl vinyl scaffold with anti-inflammatory, antidiabetic, and antioxidant potential. Discover Chemistry, 3(1), Article 549. https://doi.org/10.1007/s44371-026-01001-z

Image Credits: AI Generated

DOI: 10.1007/s44371-026-01001-z

Keywords: oligophenyl vinyl, CNR2, antioxidant, anti-inflammatory, antidiabetic, DPPH assay, alpha-amylase, alpha-glucosidase, molecular docking, molecular dynamics, Knoevenagel condensation, drug discovery

The team, led by Dounya Achwak Chemmam of the University of Jijel, grew the fungus for twenty-one days and extracted its metabolic products with ethyl acetate, a solvent chosen for its ability to pull moderately polar organic molecules out of fungal biomass. When that crude extract was tested against a panel of pathogenic microorganisms, the numbers were striking. The minimum inhibitory concentration, or MIC, the lowest dose that halts visible microbial growth, was just 7.5 micrograms per milliliter against Staphylococcus aureus ATCC 43300 and 15 micrograms per milliliter against Bacillus cereus ATCC 14579. For a raw, unfractionated extract, those values are competitive with many purified natural-product antibiotics and suggest that the active constituents are present at meaningful levels rather than as trace contaminants.

Antibacterial potency was only the beginning. The same extract showed an IC50 of 33.27 micrograms per milliliter in an anti-inflammatory assay, meaning that half of the measured inflammatory activity was suppressed at that concentration. In an antidiabetic screen targeting enzymes that break down dietary sugars, the extract achieved an IC50 of just 3.32 micrograms per milliliter, an exceptionally low figure that points to strong inhibition of carbohydrate-hydrolyzing enzymes. Inhibiting these enzymes is a validated strategy for managing blood glucose spikes after meals, and fungal metabolites have increasingly been flagged as alternatives to synthetic drugs such as acarbose. Finally, the extract exhibited antiproliferative activity with an IC50 of 124.16 micrograms per milliliter against the tested cell line, a more modest but still noteworthy effect that rounds out the pharmacological profile.

Because the activity of a fungal extract depends heavily on how the organism is grown, the researchers next turned to fermentation optimization using the one-factor-at-a-time method, systematically varying culture conditions to find the settings that maximize antimicrobial output. The tuned conditions produced dramatic gains. Against Escherichia coli, the optimized cultures generated a zone of inhibition of 19 millimeters; against Klebsiella pneumoniae, 23 millimeters; and against Bacillus cereus, an impressive 34 millimeters. That last figure is particularly significant because Bacillus cereus is a spore-forming foodborne pathogen, and activity of that magnitude against it suggests the extract could have applications well beyond the clinic, including food preservation and agricultural biocontrol.

What exactly is inside the extract? To answer that, the team deployed two complementary analytical techniques. Gas chromatography coupled to mass spectrometry, or GC-MS, separates volatile and semi-volatile compounds and fragments them into characteristic mass fingerprints that can be matched against spectral libraries. High-performance liquid chromatography, or HPLC, handles compounds that are less volatile or more thermally fragile. Together, the two methods revealed fourteen distinct metabolites produced by PB1, a chemically diverse roster that includes small organic acids, sugars, and more exotic structures.

The identified compounds read like a short course in fungal chemistry. Among them are 3-methylbutanoic acid and propanoic acid, short-chain fatty acids with documented antimicrobial effects against oral and other pathogens; ethylene glycol and 2,3-butanediol, small alcohols whose antibacterial properties have only recently attracted attention; and lactic acid alongside 2,3-dihydroxy-3-methylpropanoic acid, both hydroxy acids that can disrupt microbial membranes. The list also contains phosphorylated and siloxane-containing species, the sugars D-fructofuranose pentakis and D-psicofuranose pentakis, the plant-like glycoside erigeside B, D-galactonic acid, a bufadienolide-type steroid called bufa-20,22-dienolide, and the nucleoside uridine, a molecule that has inspired synthetic small-molecule inhibitors in medicinal chemistry.

No single one of these compounds may account for the full spectrum of activity on its own. More likely, the extract works through additive or synergistic interactions, a common feature of crude natural-product mixtures that pharmaceutical chemists are only beginning to exploit systematically. The presence of short-chain fatty acids could underpin much of the antibacterial effect, while the glycosides and the bufadienolide are plausible contributors to the cytotoxic and enzyme-inhibiting activities. Disentangling those contributions, through bioassay-guided fractionation, will be the essential next step before any clinical relevance can be claimed.

Context matters for this discovery. Penicillium citrinum is a species with a storied double reputation. On one hand, it is the original source of mevastatin, the first statin cholesterol-lowering drug, and its relatives have given medicine compounds ranging from antibiotics to immunosuppressants. On the other hand, the species is known for citrinin, a mycotoxin that contaminates grains and other foods, which means any future development of PB1-derived products would need careful toxicological scrutiny. The current study did not report citrinin among the fourteen detected metabolites, but the genus-level history is a reminder that bioactivity and toxicity often travel together in fungal chemistry and must be evaluated in parallel.

The choice of source organism is also part of the story. Almonds are a nutritionally celebrated food, and the fungi that colonize them occupy a niche that sits at the intersection of food safety and chemical innovation. Isolating a strain from a common pantry item and finding MIC values in the single-digit microgram range underscores how much pharmacological potential remains locked in ordinary environments. The Algerian team has previously described bioactive Penicillium strains from electronic waste and sea sand, and this new work extends that survey into the food chain, reinforcing the idea that productive fungi are distributed across wildly different habitats.

For now, the findings remain at the level of in vitro biochemistry: enzyme assays, microbial cultures, and cell lines, not patients. Translating a crude extract into a drug candidate typically requires years of fractionation, structural elucidation, mechanism-of-action studies, toxicity testing, and formulation work. But the comprehensive nature of this assessment, spanning antimicrobial, anti-inflammatory, antidiabetic, and antiproliferative activities alongside full chemical profiling and fermentation optimization, gives the almond fungus PB1 a unusually complete starting dossier. It is exactly the kind of well-characterized lead that natural-products researchers hope will seed the next generation of microbe-derived medicines, and it arrived, fittingly, from a handful of almonds.

Subject of Research: Bioactive secondary metabolites from an almond-derived Penicillium citrinum strain

Article Title: Unveiling the pharmacological potential of Penicillium citrinum PB1 isolated from almonds: a comprehensive bioactivity assessment

Article References: Chemmam, D. A., Hadiji-Abbes, N., Sadrati, N., Zerroug, A., Bourzama, G., Trigui, M., Bousbia, A., & Bensouici, C. (2026). Unveiling the pharmacological potential of Penicillium citrinum PB1 isolated from almonds: a comprehensive bioactivity assessment. 3 Biotech, 16(10), Article 434. https://doi.org/10.1007/s13205-026-05066-6

Image Credits: AI Generated

DOI: 10.1007/s13205-026-05066-6

Keywords: Penicillium citrinum, almonds, secondary metabolites, antimicrobial activity, MIC, anti-inflammatory, antidiabetic, alpha-glucosidase, GC-MS, HPLC, fermentation optimization, natural products

The review, led by Zaynab Ouadghiri and Othman El Faqer, together with colleagues in the Laboratory of Integrative Biology at the Faculty of Sciences Ain Chock, surveys the phytochemistry and biological activities of M. vulgare with particular emphasis on marrubiin, the furan labdane diterpene that gives the plant its characteristic bitterness and has become its most intensively studied molecule. The team’s synthesis covers antioxidant, anti-inflammatory, antimicrobial, antidiabetic, hepatoprotective, gastroprotective, cardioprotective, neuroprotective and antiproliferative effects reported across a large body of preclinical work. What emerges is a portrait of a chemically rich plant whose traditional uses are, in many cases, supported at least in principle by laboratory evidence, even as the leap to proven clinical therapy remains firmly out of reach.

The chemical arsenal of white horehound is central to the story. The plant produces a diverse suite of secondary metabolites, including diterpenoids, flavonoids, phenolic acids, tannins and volatile constituents, each class contributing differently to the observed pharmacology. Diterpenoids such as marrubiin and related labdane compounds dominate the pharmacological literature, while the phenolic fraction, rich in flavonoids and phenolic acids, underpins much of the antioxidant activity measured in extracts. Essential oils isolated from the aerial parts add antimicrobial and antifungal dimensions. This chemical diversity is a double-edged sword: it offers multiple pharmacological entry points, but it also means that extracts from different regions, harvested at different times and prepared by different methods can vary enormously in composition, complicating any attempt to compare studies or reproduce results.

Marrubiin itself has become something of a molecular celebrity in natural product research. First isolated from horehound in the nineteenth century, this bitter diterpene has been the subject of studies spanning cardiovascular protection, diabetes, inflammation and even cancer biology. Recent work highlighted in the review points to interactions with PPAR gamma, a nuclear receptor central to glucose and lipid metabolism, offering a mechanistic explanation for reported antidiabetic and anti-inflammatory effects. Researchers have also engineered delivery systems to exploit the molecule, including marrubiin-loaded solid lipid nanoparticles that showed cardioprotective effects in endothelial cell models exposed to inflammatory challenge. On the biosynthetic side, plant biologists have identified cytochrome P450 enzymes involved in marrubiin production, opening the door to metabolic engineering approaches that could yield standardized supplies of the compound without depending on variable wild harvests.

The cardiovascular findings are among the most intriguing. In isolated rat heart models, aqueous fractions of M. vulgare demonstrated protective effects against ischaemia-reperfusion injury, the cascade of damage that occurs when blood supply returns to oxygen-starved tissue. Separate studies using methanolic extracts reported inhibition of inflammatory responses and prevention of cardiomyocyte fibrosis in chemically induced myocardial infarction in rats. Extracts have also shown inhibitory activity against angiotensin I converting enzyme, the same target exploited by widely prescribed blood pressure medications. These results align neatly with the plant’s long history of use for heart complaints in Moroccan, Iranian and European traditional medicine, and they suggest that horehound-derived compounds could eventually yield leads for cardiovascular drug development, though the authors are careful to stress that isolated organ and cell models are a long way from intact human physiology.

Metabolic effects form another major pillar of the evidence. In streptozotocin-induced diabetic rats, methanolic extracts of the plant ameliorated both hyperglycemia and dyslipidemia, the twin metabolic disturbances that define type 2 diabetes and its complications. In vitro assays have shown inhibition of alpha-glucosidase, an intestinal enzyme targeted by antidiabetic drugs, while metabolomics-based studies of Algerian medicinal plants identified horehound extracts as particularly active in this regard. The anti-inflammatory data are similarly extensive, spanning carrageenan-induced paw edema in rats, antiarthritic models, antinociceptive testing and even studies of neuropathic pain following sciatic nerve injury. Immunomodulatory effects have been documented in animal models of bacterial infection, where leaf extracts altered immune responses, adding another layer to the plant’s pharmacological profile.

Perhaps the most medically ambitious claims concern protection of the brain, the liver and the gut, and the plant’s possible anticancer potential. Rat studies using scopolamine-induced cognitive impairment, a common model for memory deficits, found that horehound extracts improved spatial working memory and reduced oxidative stress damage, with behavioral improvements matched by biochemical changes. Phenylethanoid glycoside-rich extracts have shown anti-Alzheimer’s activity in vitro and in computational docking studies. In cancer research, ethanolic extracts of the plant induced proliferation arrest, apoptosis and cytoprotective autophagy in cancer cell lines, while methanolic fractions from several Marrubium species showed cytotoxic activity against melanoma cells that was independent of their antioxidant capacity, hinting at distinct mechanisms. Cytotoxicity evaluations and zebrafish embryo toxicity screening have begun to map the safety boundaries of these effects, and studies of burn wound healing have explored topical applications in combination with other medicinal plants.

Yet the review is emphatic that enthusiasm must be tempered by the quality of the underlying evidence. Nearly everything known about the pharmacology of M. vulgare comes from in vitro experiments and animal studies; clinical data in humans remain scarce to nonexistent. The authors highlight considerable variability in extract composition and experimental protocols across the literature, which makes it difficult to compare doses, identify the true active principles or establish dose-response relationships. Information on pharmacokinetics, meaning how the plant’s compounds are absorbed, distributed, metabolized and excreted in the body, is limited, as is long-term safety data. Without chemically standardized preparations, it is impossible to know whether a tea, a tincture and a subcritical extract are delivering anything remotely comparable, and mechanism-specific validation, in which a defined compound is shown to act through a defined molecular pathway, remains the exception rather than the rule.

The path forward sketched by the Moroccan team is rigorous and conventional in the best sense: chemically standardized preparations, rigorous mechanistic studies, comprehensive toxicological assessment and, only where the preclinical case justifies it, well-designed clinical trials. Advances in extraction technology, from microwave-assisted and ultrasound-assisted methods optimized by experimental design to spray drying of subcritical extracts, are making it increasingly feasible to produce consistent, high-quality horehound preparations with defined marrubiin content. Combined with metabolomic fingerprinting and in silico approaches that can predict molecular targets before bench work begins, these tools could transform horehound from a folk remedy of variable potency into a reproducible source of drug leads.

For now, white horehound sits in a familiar position for medicinal plants: rich in promise, validated by tradition and preclinical data, but unproven at the bedside. The review’s value lies precisely in its honesty about that gap. It consolidates a sprawling literature, connects the plant’s chemistry to plausible mechanisms for its traditional uses in respiratory, gastrointestinal, cardiovascular and inflammatory disorders, and lays out what must happen before marrubiin or any of its chemical cousins can be taken seriously as therapeutic agents. In an era of rising diabetes, cardiovascular disease and drug-resistant infections, the humble horehound’s chemical repertoire deserves the systematic attention it is finally receiving, and the next decade of standardized, mechanistically grounded research will determine whether this ancient bitter herb becomes a modern medicine or remains a fascinating footnote in ethnopharmacology.

Subject of Research: Phytochemistry and pharmacological activities of the medicinal plant Marrubium vulgare (white horehound) and its major diterpene marrubiin

Article Title: Comprehensive analysis of the pharmacological potentials of Marrubium vulgare (white horehound): a recent overview of phytochemistry and biological activities

Article References: Ouadghiri, Z., El Faqer, O., Wahnou, H., Rais, S., & Mtairag, E. M. (2026). Comprehensive analysis of the pharmacological potentials of Marrubium vulgare (white horehound): a recent overview of phytochemistry and biological activities. The Science of Nature, 113(5), Article 107. https://doi.org/10.1007/s00114-026-02156-6

Image Credits: AI Generated

DOI: 10.1007/s00114-026-02156-6

Keywords: Marrubium vulgare, white horehound, marrubiin, phytochemistry, medicinal plants, ethnopharmacology, antioxidant activity, anti-inflammatory, antidiabetic, cardioprotection, diterpenoids, preclinical research